DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Clinical trials for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vitamin boost help beat TB?
Disease control Recruiting nowThis study tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible tuberculosis (TB) in the lungs. About 165 adults with newly diagnosed TB will receive either the standard treatment or the standa…
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New TB combo drug trial aims to shorten treatment
Disease control Recruiting nowThis study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well in adults with drug-sensitive tuberculosis (TB). About 150 people will take part. The main goals are to see how quickly the drug combination kills TB bacteria and to check …
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC